Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other 1

Conditions

Osteosarcoma 2Renal Insufficiency 1Neoplasms 1Mucositis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cisplatin 4angiotensin I (1-7) 3Radiotherapy 3Radiation 3Injections 3Water 2RRx-001 2Interleukin 1 Receptor Antagonist Protein 2Drug Therapy 2Amifostine 2tempol 1peppermint oil 1pegfilgrastim 1kang-lai-te 1hydrated silica gel-based toothpaste 1golotimod 1glucarpidase 1fish oil triglycerides 1calcium phosphate 1brilacidin 1anise oil 1amlexanox 1aluminum hydroxide, magnesium hydroxide, drug combination 1Xylitol 1Vaccinium myrtillus extract 1Tramadol 1Therapeutics 1Surgical Procedures, Operative 1Sorbic Acid 1Sodium Bicarbonate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Mucositis × glucarpidase × Clear all
NCT02022358 2015-06-04

Will Glucarpidase After Methotrexate Treatment for Bone Sarcoma Lead to Fewer Side Effects and Reduce Chemotherapy Delays?

University College, London

Phase 2 Terminated
34 enrolled
OtherSarcoma

Osteosarcoma, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡